This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
APIDRA
SANOFI-AVENTIS CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APIDRA in Canada?
Yes. APIDRA 100UNIT has an active shortage reported to Health Canada (last updated November 10, 2026).
When will APIDRA be available again?
The manufacturer's estimated resolution date is May 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02294346
Strength
100UNIT
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Active Ingredient
INSULIN GLULISINE
Tier
Unrated
Last Updated
2026-06-18
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
APIDRA has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from SANOFI-AVENTIS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
20MCG · DIN 02464284
DIN 02464349
10MCG · DIN 02464276
100UNIT · DIN 02469898
100UNIT · DIN 02469901
100UNIT · DIN 02469871
0.58MG · DIN 02254506
500UNIT · DIN 02422913
1000UNIT · DIN 02422921
3000UNIT · DIN 02422956
2000UNIT · DIN 02422948
4000UNIT · DIN 02448157